Every step to improve lives is worth fighting for — Martin Jelsma on a 30-year drug policy struggle

The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Transnational Institute this year after decades of work, has been at the forefront of these debates. In this interview, we discuss the WHO’s coca review, inter se treaty reform, and what these shifts mean for the future of global drug policy.

Chapters
00:00 Intro
00:45 Martin, how did you get into the field of drug policy?
13:01 Did the UN drug control system learn from its mistakes?
19:15 How do you feel about the EU’s shift toward securitizing drug policy?
24:42 Should the UN drug control system be dismantled or reformed—and what would the ideal approach look like?
33:42 Would your younger self be satisfied or disappointed with today’s drug policy landscape?
35:25 What message do you have for the next generation of drug policy reformers?

Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(116)

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Mai 16min

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therap...

20 Apr 30min

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh

With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovb...

17 Apr 26min

Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and Is...

10 Apr 57min

UNGASS Promises Unfulfilled: Marie Nougier on the Challenges Facing Global Drug Policy

Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug polic...

27 Mar 16min

“I’m incredibly proud of what we built” — Ann Fordham on Leaving IDPC After 17 Years

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global...

25 Mar 20min

Sabba: Building the Future of Psychedelic Therapy Education” — Interview with Jeremy Rudy

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.Jeremy Rudy is the founder and CEO of th...

23 Mar 20min